A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2002
11/28/2002	WO2002095007A2 Conjugates activated by cell surface proteases and therapeutic uses thereof
11/28/2002	WO2002094997A2 Transcriptional regulation of target genes
11/28/2002	WO2002094990A2 Receptors and membrane-associated proteins
11/28/2002	WO2002094878A1 Hevein-binding monoclonal antibodies
11/28/2002	WO2002094863A2 INTERFERON-α INDUCED GENE
11/28/2002	WO2002094860A2 Dimerized t-cell receptor fragment, its compositions and use
11/28/2002	WO2002094833A1 Novel pyrrole derivatives as pharmaceutical agents
11/28/2002	WO2002094830A2 DIHYDROPYRROLO[1,2-A]INDOLE AND TETRAHYDROPYRIDO[1,2-a]-INDOLE DERIVATIVES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS
11/28/2002	WO2002094823A1 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors
11/28/2002	WO2002094821A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002	WO2002094814A1 3,5-diamino-1,2,4-triazoles as kinase inhibitors
11/28/2002	WO2002094811A1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002	WO2002094786A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
11/28/2002	WO2002094780A2 Kinases and phosphatases
11/28/2002	WO2002094764A1 Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use
11/28/2002	WO2002094754A1 Vitamin d analogues
11/28/2002	WO2002094322A2 Combination medicament for treatment of neoplastic diseases containing cyanoguanidine ikk inhibitors and a second anti-neoplastic drug
11/28/2002	WO2002094317A1 Methods and formulations of using a1 adenosine and p2x purinoreceptor antagonists
11/28/2002	WO2002094310A1 Anti-angiogenic and immunotherapeutic compositions for cancer treatment
11/28/2002	WO2002094304A1 The use of a gatran for the manufacture of a medicament for the treatment of pulmonary fibrosis
11/28/2002	WO2002094296A1 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
11/28/2002	WO2002094294A1 A method of implanting heavy metal such as nobel metal, e.g. gold, and metal for use in implantation
11/28/2002	WO2002094282A2 Compositions with methylprednisolone derivatives having therapeutic effect
11/28/2002	WO2002094270A2 Mip-1 alpha receptor ligands - drugs for t-cell mediated and autoimmune diseases
11/28/2002	WO2002094263A2 Caspase inhibitors and uses thereof
11/28/2002	WO2002094247A2 Use of a vitamin d3 analogue for the treatment of autoimmune diabetes
11/28/2002	WO2002094236A1 Delivery of antipsychotics through an inhalation route
11/28/2002	WO2002094203A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/28/2002	WO2002094202A2 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules
11/28/2002	WO2002094192A2 Antibodies against tumor necrosis factor delta (april)
11/28/2002	WO2002094186A2 Urazole compounds useful as anti-inflammatory agents
11/28/2002	WO2002094180A2 Pharmaceutically active isoindoline derivatives
11/28/2002	WO2002094178A2 Treatment of renal fibrosis
11/28/2002	WO2002094019A1 Highly purified antiendotoxin compound
11/28/2002	WO2002093998A2 Suppression of allergic reactions by transdermal administration of allergens in conjunction with or conjugated to toxin subunits or fragments thereof
11/28/2002	WO2002085897A8 Heterocyclic compounds for aging-related and diabetic vascular complications
11/28/2002	WO2002083712A8 Transporters and ion channels
11/28/2002	WO2002080887A3 Timed pulse release composition
11/28/2002	WO2002072631A8 Mhc molecule constructs and their usesfor diagnosis and therapy
11/28/2002	WO2002072567A3 Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
11/28/2002	WO2002070563A3 Nuclear hormone receptor ligand binding domain
11/28/2002	WO2002057741A3 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc)
11/28/2002	WO2002047711A3 Modulators of activity of g-protein-coupled receptor kinases
11/28/2002	WO2002044153A8 4-6-diphenyl pyridine derivatives as antiinflammatory agents
11/28/2002	WO2002036733A3 Cd36 as a heat shock protein receptor and uses thereof
11/28/2002	WO2002035235A3 Net as regulator of angiogenic expression
11/28/2002	WO2002024924A3 Protein phosphatases
11/28/2002	WO2002020002A3 A method for treating allergies
11/28/2002	WO2002015977A3 Methods and compositions for treating ige-related disease using nnt-1 inhibitors
11/28/2002	WO2002008255A3 Cell cycle proteins and mitosis-associated molecules
11/28/2002	WO2001095919A3 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses
11/28/2002	WO2001081415A3 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/28/2002	WO2001049277A3 Immune response modulation
11/28/2002	WO2001018021A9 B7-like polynucleotides, polypeptides, and antibodies
11/28/2002	US20020178456 Polyclonal antibodies for use inthe treatment and prevention of bacteria, fungi, virus and parasites infections
11/28/2002	US20020177839 Microprojection array having a beneficial agent containing coating
11/28/2002	US20020177723 Compounds and methods for the treatment of inflammatory and immune disorders
11/28/2002	US20020177706 Rheumatic diseases; antiarthritic agents; antitumor agents
11/28/2002	US20020177618 ERK (extracellular signal regulated kinase) inhibitors for treatment of cancer, inflammatory disorders, restenosis, and cardiovascular disease
11/28/2002	US20020177605 3-substituted isoquinolin-1-yl derivatives
11/28/2002	US20020177587 Treating sexual dysfunction including erectile dysfunction, diabetes melitus, gastrointestinal disorders, including gastric paresis and cardiovascular disorders; cyclic guanosine 3',5'-monophosphate (cGMP)
11/28/2002	US20020177565 Toso proteins and related molecules which have an inhibitory effect on TNF mediated apoptosis
11/28/2002	US20020177552 Colon tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions; alternatively, antigen presenting cell that expresses a colon tumor protein, or a T cell that is specific for cells expressing such a
11/28/2002	US20020176911 Includes xanthan gum which improves tolerance (e.g. less gastrointestinal symptoms such as emesis, stool patterns and gas)
11/28/2002	US20020176888 Oral dosage forms
11/28/2002	US20020176887 Methods of delivery of cetyl myristoleate
11/28/2002	US20020176886 Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same
11/28/2002	US20020176864 Two-domain MHC polypeptides include MHC( major histocompatibility complex) class II-based molecules that covalently linked beta 1 and alpha 1 domains, and MHC class I-based molecules that covalently linked alpha-1 and alpha-2
11/28/2002	US20020176861 A phosphate derivative when co-administered with antigens such as vaccines for bacterial and viral diseases function as immunological adjuvant
11/28/2002	US20020176856 Administering an antibody to the mammal, that binds with a specified target epitope of an antigen, associated with a tumor or an infectious agent; having engineered glycosylation site in the constant region of the heavy chain antibodies
11/28/2002	US20020176846 Storage stable powder compositions of interleukin-4 receptor
11/28/2002	DE10123586A1 New 3,5-diamino-1,2,4-triazole derivatives, are cyclin dependent kinase inhibitors useful for treating e.g. cancer, autoimmune, cardiovascular or neurodegenerative diseases or viral infections
11/28/2002	DE10123505A1 New immunoconjugate comprising egg yolk immunoglobulin Y, useful for treating e.g. inflammation or infection, is derived from specific pathogen-free hens
11/28/2002	DE10122140A1 Rekombinante Fusionsproteine und deren Trimere Recombinant fusion proteins and their trimers
11/28/2002	CA2755964A1 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
11/28/2002	CA2449442A1 Combination medicament for treatment of neoplastic diseases
11/28/2002	CA2448449A1 Treatment of renal fibrosis
11/28/2002	CA2448174A1 Compounds capable of modulating the activity and stimulating the production of a catalytic antibody
11/28/2002	CA2447940A1 Urazole compounds useful as anti-inflammatory agents
11/28/2002	CA2447795A1 Suppression of allergic reactions by transdermal administration of allergens in conjunction with or conjugated to toxin subunits or fragments thereof
11/28/2002	CA2447680A1 Hevein-binding monoclonal antibodies
11/28/2002	CA2447340A1 Kinases and phosphatases
11/28/2002	CA2447338A1 Receptors and membrane-associated proteins
11/28/2002	CA2447103A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/28/2002	CA2447023A1 Conjugates activated by cell surface proteases and therapeutic uses thereof
11/28/2002	CA2446734A1 Antibodies against tumor necrosis factor delta (april)
11/28/2002	CA2446155A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
11/28/2002	CA2446154A1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002	CA2446049A1 The use of a gatran for the manufacture of a medicament for the treatment of pulmonary fibrosis
11/28/2002	CA2445631A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002	CA2444955A1 Inactivation of genes of the mep pathway
11/28/2002	CA2444487A1 Methods and formulations of using a1 adenosine and p2x purinoreceptor antagonists
11/28/2002	CA2441801A1 Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
11/28/2002	CA2427619A1 Pharmaceutically active isoindoline derivatives
11/27/2002	EP1260816A1 Method of examining allergic diseases
11/27/2002	EP1260587A2 Tyrosyl tRNA synthetase
11/27/2002	EP1260521A2 Immunoglobulin variants for specific Fc epsilon receptors
11/27/2002	EP1260519A1 Membrane receptors for steroids and sterols
11/27/2002	EP1260504A1 Process for the preparation of antihistaminic 4-diphenylmethyl piperidine derivatives
11/27/2002	EP1260229A2 Anti-autoimmune composition comprising inhibitors of growth hormone-releasing factor activity

1 ... 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 ... 1172